Theis Skovsgaard Itenov

Medicine & Life Sciences

1. Critical Illness 100%
2. Critical Care 66%
3. Septic Shock 55%
4. Sepsis 55%
5. Intensive Care Units 53%
6. Respiratory Insufficiency 53%
7. Mortality 52%
8. Biomarkers 48%
9. Acute Kidney Injury 45%
10. Water-Electrolyte Balance 38%
11. Furosemide 35%
12. Placebos 33%
13. Cohort Studies 33%
14. Systematic Reviews 31%
15. Randomized Controlled Trials 29%
16. Thrombomodulin 28%
17. N,N-dimethylarginine 28%
18. Induced Hypothermia 25%
19. Procalcitonin 24%
20. Confidence Intervals 24%
21. Meta-Analysis 23%
22. Acute Lung Injury 23%
23. Artificial Respiration 23%
24. Platelet Endothelial Cell Adhesion Molecule-1 22%
25. Denmark 20%
26. 6-chloropenicillanic acid S-sulfoxide 19%
27. Lipocalin-2 17%
28. Sodium Potassium Chloride Symporter Inhibitors 17%
29. Electric Impedance 17%
30. Observational Studies 16%
31. Mechanical Ventilators 16%
32. Hyaluronic Acid 16%
33. Gelsolin 14%
34. Lactobacillus acidophilus 14%
35. Syndecan-1 14%
36. Hypophosphatemia 13%
37. Random Allocation 13%
38. Community-Acquired Infections 13%
39. Dabigatran 13%
40. Pulmonary Surfactant-Associated Protein D 13%
41. Severe Acute Respiratory Syndrome 13%
42. Ventilator-Associated Pneumonia 13%
43. Population 13%
44. Prospective Studies 13%
45. Coronavirus 12%
46. Lung 12%
47. Endotoxemia 12%
48. Databases 12%
49. Troponin 12%
50. Psychotropic Drugs 11%